Overall, the high intake of fat, sugar, and carbohydrates characteristic of Western dietary patterns correlates positively with IBD risk (166)
Among GH-releasing compounds, it stands out for its remarkable selectivity
It remains important to note that the selectivity data come from preclinical and early clinical models and describe no therapeutic application, but the receptor profile of the substance
related full-length recombinant thymosin beta-4 (a different formulation than the marketed TB-500 fragment) has also been examined in small human studies for cardiac and dermatologic indications Examined in preclinical models, including diabetic rat Achilles tendon and rat ligament-injury studies, for actin-binding, cell-migration, and angiogenic activity that researchers have proposed as a mechanism for tendon and ligament repair, though this literature remains comparatively sparse for musculoskeletal applications specifically Known risks and side effects: Because TB-500 is manufactured and sold without FDA oversight as a "research chemical," independent testing and industry reporting describe wide variability in purity (with some products measured well below labeled potency) and contamination with heavy metals or bacterial byproducts, unlike pharmaceutical-grade recombinant thymosin beta-4 used in registered clinical trials Thymosin beta-4's core mechanisms, angiogenesis and cell migration, are also pathways exploited by tumors
This analog lacks the first three amino acids of native IGF-1, a change that also reduces binding to IGFBPs
